Arena Reports Third Quarter Financial Results and Key Program Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
Arena Pharma (ARNA) Misses Q3 EPS by 68c
November 4, 2021 5:37 PM EDTArena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($3.21), $0.68 worse than the analyst estimate of ($2.53). Revenue for the quarter came in at $0 versus the consensus estimate of $680 thousand.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
... More